Prince Josiah Sajanthan Joseph

Prince Josiah Sajanthan Joseph

Auto-generated profile, based on publicly available information

Prince Josiah Sajanthan Joseph

University of Liverpool, Liverpool, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2022 in Epilepsia
Verified
Journal Article
Open access
YHYousif Hufthy
Yousif Hufthy
MBMahima Bharadwaj
Mahima Bharadwaj
SGShubhi Gupta
Shubhi Gupta
DHDelwar Hussain
Delwar Hussain
PJPrince Josiah Sajanthan Joseph
Prince Josiah Sajanthan Joseph
NMNasir Mirza
Nasir Mirza
Many brain insults and injuries are “epileptogenic”: they increase the risk of developing epilepsy. It is desirable to identify treatments that are “antiepileptogenic”: treatments that prevent the development of epilepsy, if administered after the occurrence of an epileptogenic insult. Current antiepileptic drugs are not antiepileptogenic, but evidence of antiepileptogenic efficacy is accumulating for a growing number of other compounds. From among these candidate compounds, statins are deserving of particular attention because statins are reported to be antiepileptogenic in more published studies and in a wider range of brain insults than any other individual or class of compounds. Although many studies report the antiepileptogenic effect of statins, it is unclear how many studies provide evidence that statins exhibit the following two essential features of a clinically viable antiepileptogenic drug: the drug must exert an antiepileptogenic effect even if it is initiated after the epileptogenic brain insult has already occurred, and the antiepileptogenic effect must endure even after the drug has been discontinued. In the current work, we interrogate published preclinical and clinical studies, to determine if statins fulfill these essential requirements. There are eight different statins in clinical use. To enable the clinical use of one of these statins for antiepileptogenesis, its antiepileptogenic effect will have to be established through future time‐ and resource‐intensive clinical trials. Therefore, it is desirable to review the published literature to determine which of the statins emerges as the most promising candidate for antiepileptogenic therapy. Hence, in the current work, we also collate and analyze published data—clinical and pre‐clinical, direct and indirect—that help to answer the question: Which statin is the most promising candidate to take forward into an antiepileptogenesis clinical trial?

1 January 2025 in The Bone & Joint Journal
Verified
Journal Article
Open access
PDF file
PTPeter Thompson
Peter Thompson
MKMohammed Khattak
Mohammed Khattak
PJP. J. Joseph
P. J. Joseph
DPDaniel C. Perry
Daniel C. Perry
TCTimothy Francis Cootes
Timothy Francis Cootes
CLClaudia Lindner
Claudia Lindner
Aims: The aims of this study were to develop an automatic system capable of calculating four radiological measurements used in the diagnosis and monitoring of cerebral palsy (CP)-related hip disease, and to demonstrate that these measurements are sufficiently accurate to be used in clinical practice.Methods: We developed a machine-learning system to automatically measure Reimer’s migration percentage (RMP), acetabular index (ACI), head shaft angle (HSA), and neck shaft angle (NSA). The system automatically locates points around the femoral head and acetabulum on pelvic radiographs, and uses these to calculate measurements. The system was evaluated on 1,650 pelvic radiographs of children with CP (682 females and 968 males, mean age 8.3 years (SD 4.5)). Each radiograph was manually measured by five clinical experts. Agreement between the manual clinical measurements and the automatic system was assessed by mean absolute deviation (MAD) from the mean manual measurement, type 1 and type 2 intraclass correlation coefficients (ICCs), and a linear mixed-effects model (LMM) for assessing bias.Results: The MAD scores were 5.7% (SD 8.5%) for RMP, 4.3° (SD 5.4°) for ACI, 5.0° (SD 5.2°) for NSA, and 5.7° (SD 6.1°) for HSA. Overall ICCs quantifying the agreement between the mean manual measurement and the automatic results were 0.91 for RMP, 0.66 for ACI, 0.85 for NSA, and 0.73 for HSA. The LMM showed no statistically significant bias.Conclusion: The results showed excellent agreement between the manual and automatic measurements for RMP, good agreement for NSA, and moderate agreement for HSA and ACI. The performance of the system is sufficient for application in clinical practice to support the assessment of hip migration based on RMP. The system has the potential to save clinicians time and to improve patient care by enabling more comprehensive, consistent, and reliable monitoring of hip migration in children with CP.Cite this article: Bone Joint J 2025;107-B(1):124–132.

1 November 2023 in Bone & Joint Open
Verified
Journal Article
Open access
PDF file
PJPrince J. S. Joseph
Prince J. S. Joseph
MKMohammed Khattak
Mohammed Khattak
SMSundas T. Masudi
Sundas T. Masudi
LMLouise Minta
Louise Minta
DPDaniel C. Perry
Daniel C. Perry
Radiological assessment of hip disease in children with cerebral palsy: development of a core measurement set

27 July 2024 in Arthroplasty Today
Verified
Journal Article
Open access
AAAlexander Abouharb
Alexander Abouharb
PJPrince Josiah Sajanthan Joseph
Prince Josiah Sajanthan Joseph
HPHemant Pandit
Hemant Pandit
Metal sensitivity is a possible cause for revision in elective lower-limb arthroplasty. This scoping review aims to identify and evaluate all existing and novel assessment methods for metal sensitivity in elective lower-limb arthroplasty. The Cochrane Central Register of Controlled Trials (CENTRAL), Ovid Medical Literature Analysis and Retrieval System Online (MEDLINE), PubMed, and Google Scholar databases were searched for studies published between January 1, 2000, and September 1, 2023. Studies evaluating one or more metal sensitivity assessment method preoperatively, perioperatively, or postoperatively were included. Studies were grouped based on the assessment methods reported and summarized based on the study design, outcome measure, results, and comments on the method’s validity. A total of 1220 results were screened, with 39 results (15 retrospective cohort studies, 11 prospective cohort studies, 6 case reports, 5 randomized controlled trials, and 2 case control studies) included, identifying 12 assessment methods. The most used one was patch testing, featuring in 17 studies (43.6%). Lymphocyte transformation assay/testing featured in 12 studies (30.8%). Plasma/serum concentration of metal ions featured in 6 studies (15.4%). Patient history and serum cytokine testing featured in 7 (17.9%) and 4 (10.3%) studies each. Generalized serum inflammatory markers featured in 3 studies (7.7%). The remaining 6 methods each featured in one or 2 studies. Evidence of the reliability of most metrics was limited. Several assessment methods were identified. However, evidence of any methods reliably predicting and diagnosing the occurrence of metal sensitivity was limited. There is a need for improved metrics of metal hypersensitivity.

11 September 2023 in JMIR Medical Education
Verified
Journal Article
Open access
TFTaylor Fulton-Ward
Taylor Fulton-Ward
RBRobert Bain
Robert Bain
Emma G KhouryEmma G Khoury
Emma G Khoury
SKSumirat Mandan Keshwara
Sumirat Mandan Keshwara
PJPrince Josiah S Joseph
Prince Josiah S Joseph
CMChristopher P. Millward
Christopher P. Millward
Background: Formal education of oncology is lacking in many undergraduate medical curricula. Mentoring schemes can expose participants to specific areas of medicine and may address the shortfalls in oncology education. Few mentoring schemes have been designed within the United Kingdom, especially within oncology. There is a need to understand reasons for mentor and mentee participation in such schemes and to identify ways to minimize barriers to engagement. Objective: This study identifies motivations for participation in an oncology mentoring scheme and its benefits and limitations to both the mentee and the mentor. Methods: The British Oncology Network for Undergraduate Societies launched a National Oncology Mentorship Scheme (NOMS) on September 1, 2021. Mentees (medical student or foundation doctor) were paired with mentors (specialty registrar or consultant), for 6 months of mentoring. In total, 86 mentors and 112 mentees were recruited to the scheme. The mentees and mentors were asked to meet at least 3 times during this period and suggestions were provided on the content of mentoring. Mentees and mentors were invited to complete a prescheme questionnaire, exploring motivations for involvement in the scheme, current experiences within oncology, and knowledge and interests in the field. At the end of the scheme, mentors and mentees were asked to complete a postscheme questionnaire exploring experiences and benefits or limitations of participation. Paired analysis was performed using the Wilcoxon signed-rank test. For free text data, content analysis was applied to summarize the main themes in the data. Results: Of the 66 (59%) mentees who completed the prescheme questionnaire, 41 (62%) were clinical, 21 (32%) preclinical medical students, and the remainder were junior doctors. For mentees, networking was the primary reason for joining the scheme (n=25, 38%). Mentees ranked experience of oncology at medical school at 3 on 10 (IQR 2-5). In this, 46 (53%) mentors completed the prescheme questionnaire, 35 (76%) were registrar level, and the remainder were consultant level (n=11). The most common reason for mentor participation was to increase awareness and interest in the field (n=29, 63%). Of those who completed the prescheme questionnaire, 23 (35%) mentees and 25 (54%) mentors completed the postscheme questionnaire. Knowledge in all areas of oncology assessed significantly increased during the scheme (P<.001). Most mentees (n=21, 91%) and mentors (n=18, 72%) felt they had benefited from the scheme. Mentees cited gaining insights into oncology as most beneficial; and mentors, opportunities to develop professionally. Whilst mentees did not report any barriers to participating in the scheme, mentors stated lack of time as the greatest barrier to mentoring. Conclusions: British Oncology Network for Undergraduate Societies’ NOMS is expanding and is beneficial for mentees through increasing knowledge, providing exposure, and career advice in oncology. Mentors benefit from improving their mentoring skills and personal satisfaction.

4 June 2021 in Heart
Verified
Conference Paper
Open access
PDF file
RAReham Awad
Reham Awad
PJPrince Joseph
Prince Joseph
EOEmily Owen
Emily Owen
SKShamshad Khan
Shamshad Khan
MHMohammed Hilal-Babu
Mohammed Hilal-Babu
ARAmna Rahman
Amna Rahman
Introduction - Acute Heart failure inpatient mortality is as high as 7-11% in UK National Heart Failure audits with little improvement over many years. Some but not all studies have suggested a possible weekend effect on mortality in different patient groups including patients suffering from heart failure. However, some studies failed to recognise admissions after 5pm on Fridays as weekend. We aim to determine in a large cohort of heart failure admissions whether patients are less likely to survive if admitted during weekend or Bank Holidays. Methods - A retrospective study of consecutive admissions with heart failure as 1st diagnostic position in Blackpool Victoria Hospital over an 18 month period from 1st August 2019 to 31st January 2021. Normal working hours is defined as 9am to 5pm during weekdays except UK Bank holidays. Results - Of 1178 episodes of heart failure admission, there were 140 inpatient deaths (11.9%). Median age at admission was 80 [interquartile range 70, 86]. 48 (4.1%) were COVID positive, 34% negative. 60.4% were not tested. 405 patients were admitted over the weekend/bank holiday (34.4%) . The other 773 patients (65.6%) were admitted during normal working hours (9am to 5pm during weekdays). The length of stay is not significantly different whether patients are admitted over weekend /bank holidays or during normal working hours {median 11 days [5, 19] vs 11 days [5,21] admitted during normal working hours, p=0.48}. Inpatient mortality in patients admitted with heart failure over the weekend/bank holiday was 1.3 times higher, but this apparent increased risk was not statistically significant (95% confidence interval of the odds ratio=0.98-1.8, Fisher exact 2-tailed p= 0.2). Conclusion There is no significant difference in inpatient mortality between patients admitted with heart failure during normal working hours or during weekends and bank holidays. Future research will explore reasons (including the use of evidence based drugs, timely diagnosis with echocardiography and the impact of COVID). Conflict of Interest Heart Failure